Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics
Type of information:
(Q)SAR
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: QSAR prediction of toxicokinetic properties, based on chemical structure and physicochemical properties
Justification for type of information:
QSAR prediction: migrated from IUCLID 5.6

Data source

Reference
Reference Type:
other: QSAR Toolbox output
Title:
No information
Author:
OECD QSAR Toolbox version 3.1
Year:
2013

Materials and methods

Objective of study:
toxicokinetics
Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
QSAR prediction of toxicokinetic properties, based on chemical structure and physicochemical properties
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
1,8-diazabicyclo[5.4.0]undec-7-ene
EC Number:
229-713-7
EC Name:
1,8-diazabicyclo[5.4.0]undec-7-ene
Cas Number:
6674-22-2
Molecular formula:
C9H16N2
IUPAC Name:
2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine
Test material form:
other: not applicable
Details on test material:
Not applicable; QSAR predictions based on chemical structure and physicochemcial
Radiolabelling:
other: not applicable

Test animals

Species:
other: not applicable
Details on test animals or test system and environmental conditions:
not applicable

Administration / exposure

Route of administration:
other: prediction of bioavailability relates to oral exposure
Details on exposure:
not applicable

Results and discussion

Main ADME resultsopen allclose all
Type:
absorption
Results:
oral bioavailability is predicted
Type:
metabolism
Results:
no hepatic metabolism is predicted
Type:
metabolism
Results:
no dermal metabolism is predicted

Toxicokinetic / pharmacokinetic studies

Details on absorption:
Oral bioavailability is predicted (Lipinski Rule / OASIS)
Details on distribution in tissues:
No data
Details on excretion:
No data

Metabolite characterisation studies

Metabolites identified:
no
Details on metabolites:
Rat liver S9 metabolism simulator does not predict any metabolites
Skin metabolism simulator does not predict any metabolites

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): bioaccumulation potential cannot be judged based on study results
Modelling using OECD QSAR Toolbox version 3.1 predicts bioavailability and no metabolism.
Executive summary:

QSAR predictions of toxicokinetic properties were obatined, based on chemical structure and physicochemical properties of the substance. Modelling using OECD QSAR Toolbox version 3.1 predicts bioavailability (Lipinski's Rule/OASIS) and no hepatic or dermal metabolism.